All In MedTech

Device Trial Radar · NCT05490459

Jewel Electrophysiology (EP) Lab Study

Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

18

Actual

Start

Nov 27, 2018

Primary completion

Oct 7, 2021

Study completion Apr 17, 2024

Sponsor

Lead sponsor
Element Science, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 5, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single arm open label evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) defibrillation waveform in adult cardiac patients.

Conditions

  • Sudden Cardiac Arrest

Interventions

  • Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)Device

    Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Effectiveness of the JewelTime frame: Immediately following defibrillation with the study device.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nemocnice Na Homolce Hospital

    Prague, Czechia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.